• Career
  • Support
  • Contact Us
Menu
  • Career
  • Support
  • Contact Us
  • Solutions
    • Medical Device Services
    • Medical Research Services
  • Get Started
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
Menu
  • Solutions
    • Medical Device Services
    • Medical Research Services
  • Get Started
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
Search
Close
Menu
  • Solutions
    • Medical Device Services
    • Medical Research Services
  • Get Started
    • Get a Quote
    • Get Set Up
  • News & Events
    • News
    • Events
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
  • Career
  • Support
  • Contact Us
  • All posts

AMRA Medical’s MRI-Based Fat & Muscle Assessment Technology Approved for Clinical Use in US and Canada

  • February 23, 2022
Share on twitter
Share on linkedin
Share on facebook
Share on email

LINKÖPING, Sweden; February 23, 2022—AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis offering medical device and medical research services, announced today that AMRA has received 510(k) clearance from the FDA and MDEL (Medical Device Establishment Licence) licensing. AMRA is now permitted to distribute AMRA® BCP Scan (Body Composition Profile) in the US and Canada. The BCP Scan uses muscle and fat biomarkers from magnetic resonance imaging (MRI) scans to provide objective and actionable data to clinicians.

The AMRA® BCP Scan is offered as a medical device service to promote health and wellness. The technology utilizes AMRA’s rapid neck-to-knee MRI protocol, to produce an easy-to-understand and actionable patient-specific report. The report contains patient-specific body composition measurements, such as muscle, fat, and liver fat volumes, with a comparison to normative values based on AMRA’s reference database. The report goes further to compare the patient with others of the same sex and body habitus, making the results even more personalized. The body composition measurements derived from the MR images provide information that may promote healthy lifestyle choices. For instance, if the BCP Scan detects a high level of visceral fat—which is associated with a higher risk of type 2 diabetes and heart disease—a physician evaluating the results may decide to encourage a lifestyle change of his or her patient that has been shown to reduce visceral fat.

Eric Converse, CEO at AMRA, commented: “We are thrilled to expand this technology to the US and Canada. The AMRA® BCP Scan brings health assessment into a new era. Rather than relying on BMI or waist circumference, we have precise fat and muscle measurements so a physician can really see what is going on inside the body.” Converse continued: “Our protocol only adds minutes to an already prescribed MRI, and because we deliver the results through a simple report, clinicians and patients can easily understand the information and potentially use that information to make healthy lifestyle choices.”

Learn more about the AMRA® BCP Scan on AMRA’s website.

  • All posts
Share on twitter
Share on linkedin
Share on facebook
Share on email

AMRA Medical is a digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition analysis, delivering multiple fat and muscle biomarkers with unrivaled accuracy and precision – all from a rapid whole-body MRI scan.

AMRA offers medical device and medical research services to support transformative care and vital decision-making, from clinical research to clinical care.

Contact

  • info@amramedical.com
  • +46 (0) 13 16 26 00
  • Contact Our Support
Follow us
Linkedin Twitter Facebook

Newsletter

    • Data Privacy Policy
    • Cookies
    Menu
    • Data Privacy Policy
    • Cookies

    © 2022 AMRA Medical AB

    By using our site, you acknowledge that you have read and understood our privacy policy. We use cookies to ensure you have the best browsing experience on our website.
    Accept & Close